Investigatory and analytical approaches to differential gene expression profiling in mantle cell lymphoma

British Journal of Haematology

Volumn 119, Issue 4, 2002, Pages 905-915

  Zhu, Ying ^a   Hollmén, Jaakko ^b   Räty, Riikka ^a   Aalto, Yan ^a   Nagy, Balint ^a,c   Elonen, Erkki ^a   Kere, Juha ^a   Mannila, Heikki ^b   Franssila, Kaarle ^a   Knuutila, Sakari ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b AALTO UNIVERSITY   (Finland)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Array analysis; Blastoid variant; Differential expression; Mantle cell lymphoma

Indexed keywords

CD23 ANTIGEN; CD45 ANTIGEN; CD70 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; COMPLEMENTARY DNA; GLYCOPROTEIN GP 130; PROTEIN BCL 2; RGS PROTEIN; STAT3 PROTEIN;

ACCURACY; ADULT; AGED; ANX2 GENE; ARTICLE; BAYES THEOREM; BCL1 GENE; CD44H GENE; CD66D GENE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GRN GENE; HUMAN; MALE; MALIGNANT TRANSFORMATION; MANTLE CELL LYMPHOMA; METASTASIS; NFATC GENE; ONCOGENE; ONCOGENE C MYC; ONCOGENE PIM1; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; REGRESSION ANALYSIS; TOP1 GENE; TUMOR PROMOTION; TUMOR SUPPRESSOR GENE;

AGED; AGED, 80 AND OVER; BAYES THEOREM; DNA, COMPLEMENTARY; DNA, NEOPLASM; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; PRINCIPAL COMPONENT ANALYSIS; REGRESSION ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 18744411789     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03931.x     Document Type: Article

References (46)

1. Amason, R., Sigaux, F., Frzedborski, S., Flandrin, G., Givol, D. & Telerman, A. (1989) The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias. Proceedings of the National Academy of Sciences of the United States of America, 86, 8857-8861.
2. Beà, S., Ribas, M., Hernández, J.M., Bosch, F., Pinyol, M., Hernández, L., García, J.L., Flores, T., González, M., López-Guillermo, A., Piris, M.A., Cardesa, A., Montserrat, E., Miró, R. & Campo, E. (1999) Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants. Blood, 93, 4365-4374.
3. Bowman, E.P., Campbell, J.J., Druey, K.M., Scheschonka, A., Kehrl, J.H. & Butcher, E.C. (1998) Regulation of chemotactic and proadhesive responses to chemoattractant receptors by RGS (regulator of G-protein signaling) family members. Journal of Biological Chemistry, 273, 28040-28048.
4. Breuer, M., Slebos, R., Verbeek, S., van Lohuizen, M., Wientjens, E. & Berns, A. (1989) Very high frequency of lymphoma induction by a chemical carcinogen in pim-1 transgenic mice. Nature, 340, 61-63.
5. Cesarman, G.M., Guevara, C.A. & Hajjar, K.A. (1994) An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation. Journal of Biological Chemistry, 269, 21198-21203.
6. Chung, C.Y., Murphy-Ullrich, J.E. & Erickson, H.P. (1996) Mitogenesis, cell migration, and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor, annexin II. Molecular Biology of the Cell, 7, 883-892.
7. Dang, C.V., Resar, L.M.S., Emison, E., Kim, S., Li, Q., Prescott, J.E., Wonsey, D. & Zeller, K. (1999) Function of the c-Myc oncogenic transcription factor. Experimental Cell Research, 253, 63-77.
8. Duda, R.O., Peter, E.H. & Stork, D.G. (2001) Pattern Classification, 2nd Edn. John Wiley & Sons, New York.
9. Fisher, R.I., Dahlberg, S., Nathwani, B.N., Banks, P.M., Miller, T.P. & Grogan, T.M. (1995) A clinical analysis of two indolent lymphoma entities: Mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): A Southwest Oncology Group study. Blood, 85, 1075-1082.
10. Golub, T.R., Slonim, D.K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J.P., Coller, H., Loh, M.H., Downing, J.R., Caligiuri, M.A., Bloomfield, C.D. & Lander, E.S. (1999) Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science, 286, 531-537.
11. Greiner, T.C., Moynihan, M.J., Chan, W.C., Lytle, D.M., Pedersen, A., Anderson, J.R. & Weisenburger, D.D. (1996) p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis. Blood, 87, 4302-4310.
12. Hilsenbeck, S.G., Friedrichs, W.E., Schiff, R., O'Connell, P., Hansen, R.K., Osborne, C.K. & Fuqua, S.A.W. (1999) Statistical analysis of array expression data as applied to the problem of tamoxifen resistance. Journal of the National Cancer Institute, 91, 453-459.
13. Jaffe, E.S., Bookman, M.A. & Longo, D.L. (1987) Lymphocytic lymphoma of intermediate differentiation-mantle zone lymphoma: A distinct subtype of B-cell lymphoma. Human Pathology, 18, 877-880.
14. Kehrl, J.H. (1998) Heterotrimeric G protein signaling: Roles in immune function and fine-tuning by RGS proteins. Immunity, 8, 1-10.
15. Kiuchi, N., Nakajima, K., Ichiba, M., Fukada, T., Narimatsu, M., Mizuno, K., Hibi, M. & Hirano, T. (1999) STAT3 is required for the gp130-mediated full activation of the c-myc gene. Journal of Experimental Medicine, 189, 63-73.
16. Kleinerman, D.I., Troncosco, P., Lin, S.-H., Pisters, L.L., Sherwood, E.R., Brooks, T., von Eschenbach, A.C. & Hsieh, J.-T. (1995) Consistent expression of an epithelial cell adhesion molecule (C-CAM) during human prostate development and loss of expression in prostate cancer: Implication as a tumor suppressor. Cancer Research, 55, 1215-1220.
17. Kleinerman, D.I., Dinney, C.P.N., Zhang, W.-W., Van Lin, S.-H., N.T. & Hsieh, J.-T. (1996) Suppression of human bladder cancer growth by increased expression of C-CAM1 gene in an orthotopic model. Cancer Research, 56, 3431-3435.
18. Kunath, T., Ordonez-Garcia, C., Turbide, C. & Beauchemin, N. (1995) Inhibition of colonic tumor cell growth by biliary glycoprotein. Oncogene, 11, 2375-2382.
19. Lardelli, P., Bookman, M.A., Sundeen, J., Longo, D.L. & Jaffe, E.S. (1990) Lymphocytic lymphoma of intermediate differentiation. Morphologic and immunologic spectrum and clinical correlations. American Journal of Surgical Pathology, 14, 752-763.
20. Lens, S.M., Keehnen, R.M., van Oers, M.H., van Lier, R.A., Pals, S.T. & Koopman, G. (1996) Identification of a novel subpopulation of germinal center B cells characterized by expression of IgD and CD70. European Journal of Immunology, 26, 1007-1011.
21. Lens, S.M.A., Drillenburg, P., den Drijver, B.F.A., van Schijndel, G., Pals, S.T., van Lier, R.A.W. & van Oers, M.H.J. (1999) Aberrant expression and reverse signalling of CD70 on malignant B cells. British Journal of Haematology, 106, 491-503.
22. van Lohuizen, M., Verbeek, S., Krimpenfort, P., Domen, J., Saris, C., Radaszkiewicz, T. & Berns, A. (1989) Predisposition to lymphomagenesis in pim-1 transgenic mice: Cooperation with c-myc and N-myc in murine leukemia virus-induced tumors. Cell, 56, 673-682.
23. van Lohuizen, M., Verbeek, S., Scheijen, B., Wientjens, E., van der Gulden, H. & Berns, A. (1991) Identification of cooperating oncogenes in m-myc transgenic mice by provirus tagging. Cell, 65, 737-752.
24. Luo, W., Wood, C.G., Earley, K., Hung, M.-C. & Lin, S.-H. (1997) Suppression of tumorigenicity of breast cancer cells by an epithelial cell adhesion molecule (C-CAM): The adhesion and growth suppression are mediated by different domains. Oncogene, 14, 1697-1704.
25. Mai, J., Finley, R.L.J., Waisman, D.M. & Sloane, B.F. (2000a) Human procathepsin B interacts with the annexin II tetramer on the surface of tumor cells. Journal of Biological Chemistry, 275, 12806-12812.
26. Mai, J., Waisman, D.M. & Sloane, B.F. (2000b) Cell surface complex of cathepsin B/annexin II tetramer in malignant progression. Biochimica et Biophysica Acta, 1477, 215-230.
27. Monni, O., Zhu, Y., Franssila, K., Oinonen, R., Elonen, E., Höglund, P., Joensuu, H. & Knuutila, S. (1999) Molecular characterization of the deletion at 11q22.1-q23.3 in mantle cell lymphoma. British Journal of Haematology, 104, 665-671.
28. Moratz, C., Kang, V.H., Druey, K.M., Shi, C.S., Scheschonka, A., Murphy, P.M., Kozasa, T. & Kehrl, J.H. (2000) Regulator of G protein signaling 1 (RGS1) markedly impairs Gi alpha signaling responses of B lymphocytes. Journal of Immunology, 164, 1829-1838.
29. Obrink, B. (1997) CEA adhesion molecules: Multifunctional proteins with signal-regulatory properties. Current Opinion of Cell Biology, 9, 616-626.
30. Oliferenko, S., Paiha, K., Harder, T., Gerke, V., Schwarzler, C., Schwarz, H., Beug, H., Gunthert, U. & Huber, L.A. (1999) Analysis of CD44-containing lipid rafts: Recruitment of annexin II and stabilization by the actin cytoskeleton. Journal of Cell Biology, 146, 843-854.
31. Ott, G., Kalla, J., Ott, M.M., Schryen, B., Katzenberger, T., Muller, J.G. & Muller-Hermelink, H.K. (1997) Blastoid variants of mantle cell lymphoma: Frequent bcl-1 rearrangements at the major translocation cluster region and tetraploid chromosome clones. Blood, 89, 1421-1429.
32. Ott, M.M., Ott, G., Kuse, R., Porowski, P., Gunzer, U., Feller, A.C. & Müller-Hermelink, H.K. (1994) The anaplastic variant of centrocytic lymphoma is marked by frequent rearrangements of the bcl-1 gene and high proliferation indices. Histopathology, 24, 329-334.
33. Waf1 genes are associated with aggressive variants of mantle cell lymphomas. Blood, 89, 272-280.
34. 16INK4a gene in activation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas. Blood, 91, 2977-2984.
35. Pommier, Y., Leteurtre, F., Fesen, M.R., Fujimori, A., Bertrand, R., Solary, E., Kohlhagen, G. & Kohn, K.W. (1994) Cellular determinants of sensitivity and resistance to DNA topoisomerase inhibitors. Cancer Investigation, 12, 530-542.
36. Ponta, H. & Herrlich, P. (1998) The CD44 protein family: Roles in embryogenesis and tumor progression. Frontiers in Biosciences, 3, 650-656.
37. Rao, A., Luo, C. & Hogan, P.G. (1997) Transcription factors of the NFAT family: Regulation and function. Annual Review of Immunology, 15, 707-747.
38. Reif, K. & Cyster, J.G. (2000) RGS molecule expression in murine B lymphocytes and ability to down-regulate chemotaxis to lymphoid chemokines. Journal of Immunology, 164, 4720-4729.
39. Schaffner, C., Idler, I., Stilgenbauer, S., Döhner, H. & Lichter, P. (2000) Mantle cell lymphoma is characterized by inactivation of the ATM gene. Proceedings of the National Academy of Sciences of the United States of America, 97, 2773-2778.
40. Sembries, S., Pahl, H., Stilgenbauer, S., Döhner, H. & Schriever, F. (1999) Reduced expression of adhesion molecules and cell signaling receptors by chronic lymphocytic leukemia cells with 11q-deletion. Blood, 93, 624-631.
41. Shirogane, T., Fukada, T., Muller, J.M.M., Shima, D.T., Hibi, M. & Hirano, T. (1999) Synergic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapopotosis. Immunity, 11, 709-719.
42. Smid-Koopman, E., Blok, L.J., Chadha-Ajwani, S., Helmerhorst, T.J.M., Brinkmann, A.O. & Huikeshoven, F.J. (2000) Gene expression profiles of human endometrial cancer samples using a cDNA-expression array technique: Assessment of an analysis method. British Journal of Cancer, 83, 246-251.
43. Thompson, J.A., Grunert, F. & Zimmerman, W. (1991) Carcinoembryonic antigen gene family: Molecular biology and clinical perspectives. Journal of Clinical Laboratory Analysis, 5, 344-366.
44. Yatabe, Y., Suzuki, R., Tobinai, K., Matsuno, Y., Ichinohasama, R., Okamoto, M., Yamaguchi, M., Tamaru, J., Uike, N., Hashimoto, Y., Morishima, Y., Suchi, T., Seto, M. & Nakamura, S. (2000) Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: A clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like-B-cell lymphoma. Blood, 95, 2253-2261.
45. Zhu, Y., Monni, O., Franssila, K., Elonen, E., Vilpo, J., Joensuu, H. & Knuutila, S. (2000) Deletions at 11q23 in different lymphoma subtypes. Haematologica, 85, 908-912.
46. Zukerberg, L.R., Medeiros, L.J., Ferry, J.A. & Harris, N.L. (1993) Diffuse low-grade B-cell lymphomas. Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features. American Journal of Clinical Pathology, 100, 373-385.